BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31069976)

  • 61. BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia.
    Rizzotto L; Saccenti E; Sofritti O; Daghia G; Volta E; Caprini E; Lupini L; Tammiso E; Bardi A; Lista E; Ciccone M; Russo G; Negrini M; Cuneo A; Rigolin GM
    Leuk Lymphoma; 2013 Sep; 54(9):2065-7. PubMed ID: 23323950
    [No Abstract]   [Full Text] [Related]  

  • 62. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
    Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
    J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options.
    Khan M; Siddiqi R; Tran TH
    Semin Hematol; 2018 Oct; 55(4):235-241. PubMed ID: 30502852
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
    Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
    Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p210 BCR-ABL1 positive pediatric B-lineage acute lymphoblastic leukemia presenting with hypercalcemia.
    Bommannan K; Totadri S; Sachdeva MU; Naseem S; Trehan A; Varma N
    Leuk Lymphoma; 2017 Feb; 58(2):501-502. PubMed ID: 27339816
    [No Abstract]   [Full Text] [Related]  

  • 67. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on
    Hrabovsky S; Vrzalova Z; Stika J; Jelinkova H; Jarosova M; Navrkalova V; Martenek J; Folber F; Salek C; Horacek JM; Pospisilova S; Mayer J; Doubek M
    Acta Oncol; 2021 Jun; 60(6):760-770. PubMed ID: 33750258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. γ-Catenin-Dependent Signals Maintain BCR-ABL1
    Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
    Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
    Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
    Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.
    Tharkar-Promod S; Johnson DP; Bennett SE; Dennis EM; Banowsky BG; Jones SS; Shearstone JR; Quayle SN; Min C; Jarpe M; Mosbruger T; Pomicter AD; Miles RR; Chen WY; Bhalla KN; Zweidler-McKay PA; Shrieve DC; Deininger MW; Chandrasekharan MB; Bhaskara S
    Leukemia; 2018 Jan; 32(1):49-60. PubMed ID: 28579617
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IK6 isoform with associated cytogenetic and molecular abnormalities in Chinese patients with Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
    Yao L; Cen J; Chen S; Shen H; Chen Y; He J; Chen Z
    Leuk Lymphoma; 2013 Aug; 54(8):1626-32. PubMed ID: 23150929
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
    Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
    Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
    Moore FR; Yang F; Press RD
    Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.
    Wenzinger C; Williams E; Gru AA
    Curr Hematol Malig Rep; 2018 Aug; 13(4):275-288. PubMed ID: 29951888
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell.
    Ragg S; Zehentner BK; Loken MR; Croop JM
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27829. PubMed ID: 31136068
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
    Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.